Biomarker-based prediction of inflammatory bowel disease-related colorectal cancer: a case-control study

Monique M. Gerrits, Wei-Min Chen, Myrte J G A Theeuwes, Herman van Dekken, Marjolein Sikkema, Ewout W. Steyerberg, Hester F. Lingsma, Peter D. Siersema, Bing Xia, Johannes G. Kusters, C. Janneke van der Woude, Ernst J. Kuipers

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)107-117
JournalCellular oncology
Volume34
Issue number2
DOIs
Publication statusPublished - Apr 2011

Keywords

  • Inflammatory bowel disease
  • Colorectal cancer
  • Surveillance
  • Abnormal DNA ploidy
  • p53 immunopositivity

Cite this

Gerrits, M. M., Chen, W-M., Theeuwes, M. J. G. A., van Dekken, H., Sikkema, M., Steyerberg, E. W., Lingsma, H. F., Siersema, P. D., Xia, B., Kusters, J. G., van der Woude, C. J., & Kuipers, E. J. (2011). Biomarker-based prediction of inflammatory bowel disease-related colorectal cancer: a case-control study. Cellular oncology, 34(2), 107-117. https://doi.org/10.1007/s13402-010-0006-4